116 related articles for article (PubMed ID: 9305615)
1. Time-course of butyric acid-induced differentiation in human K562 leukemic cell line: rapid increase in gamma-globin, porphobilinogen deaminase and NF-E2 mRNA levels.
Chénais B; Molle I; Trentesaux C; Jeannesson P
Leukemia; 1997 Sep; 11(9):1575-9. PubMed ID: 9305615
[TBL] [Abstract][Full Text] [Related]
2. Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells.
Morceau F; Aries A; Lahlil R; Devy L; Jardillier JC; Jeannesson P; Trentesaux C
Biochem Pharmacol; 1996 Mar; 51(6):839-45. PubMed ID: 8602880
[TBL] [Abstract][Full Text] [Related]
3. Requirement of GATA-1 and p45 NF-E2 expression in butyric acid-induced erythroid differentiation.
Chénais B
Biochem Biophys Res Commun; 1998 Dec; 253(3):883-6. PubMed ID: 9918824
[TBL] [Abstract][Full Text] [Related]
4. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of tellimagrandin I on chemically induced differentiation of human leukemia K562 cells.
Yi Z; Wang Z; Li H; Liu M
Toxicol Lett; 2004 Mar; 147(2):109-19. PubMed ID: 14757314
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells.
Morceau F; Chénais B; Gillet R; Jardillier JC; Jeannesson P; Trentesaux C
Cell Growth Differ; 1996 Aug; 7(8):1023-9. PubMed ID: 8853898
[TBL] [Abstract][Full Text] [Related]
7. Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: the effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer.
Miller JL; Walsh CE; Ney PA; Samulski RJ; Nienhuis AW
Blood; 1993 Sep; 82(6):1900-6. PubMed ID: 8400240
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
Trentesaux C; Nyoung MN; Aries A; Morceau F; Ronchi A; Ottolenghi S; Jardillier JC; Jeannesson P
Leukemia; 1993 Mar; 7(3):452-7. PubMed ID: 8445949
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
10. The benzophenanthridine alkaloid fagaronine induces erythroleukemic cell differentiation by gene activation.
Dupont C; Couillerot E; Gillet R; Caron C; Zeches-Hanrot M; Riou JF; Trentesaux C
Planta Med; 2005 Jun; 71(6):489-94. PubMed ID: 15971117
[TBL] [Abstract][Full Text] [Related]
11. A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells.
Berkovitch-Luria G; Yakobovitch S; Weitman M; Nudelman A; Rozic G; Rephaeli A; Malik Z
Eur J Pharm Sci; 2012 Aug; 47(1):206-14. PubMed ID: 22705251
[TBL] [Abstract][Full Text] [Related]
12. Erythroid gene suppression by NF-kappa B.
Liu JJ; Hou SC; Shen CK
J Biol Chem; 2003 May; 278(21):19534-40. PubMed ID: 12642582
[TBL] [Abstract][Full Text] [Related]
13. Identification of GATA-1 and NF-E2 binding sites in the flanking regions of the human alpha-globin genes.
Gourdon G; Morlé F; Roche J; Tourneur N; Joulain V; Godet J
Acta Haematol; 1992; 87(3):136-44. PubMed ID: 1642094
[TBL] [Abstract][Full Text] [Related]
14. Expression of transcription factors during sodium phenylacetate induced erythroid differentiation in K562 cells.
Rath AV; Schmahl GE; Niemeyer CM
Blood Cells Mol Dis; 1997; 23(1):27-38. PubMed ID: 9215748
[TBL] [Abstract][Full Text] [Related]
15. The activation domain of the enhancer binding protein p45NF-E2 interacts with TAFII130 and mediates long-range activation of the alpha- and beta-globin gene loci in an erythroid cell line.
Amrolia PJ; Ramamurthy L; Saluja D; Tanese N; Jane SM; Cunningham JM
Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10051-6. PubMed ID: 9294161
[TBL] [Abstract][Full Text] [Related]
16. A novel erythroid differentiation related gene EDRF1 upregulating globin gene expression in HEL cells.
Wang D; Li Y; Shen B
Chin Med J (Engl); 2002 Nov; 115(11):1701-5. PubMed ID: 12609092
[TBL] [Abstract][Full Text] [Related]
17. 3'-Azido-3'-deoxythymidine inhibits erythroid-specific transcription factors in human erythroid K562 leukemia cells.
Bridges EG; Trentesaux C; Lahlil R; Spiga MG; Jeannesson P; Sommadossi JP
Eur J Haematol; 1996; 56(1-2):62-7. PubMed ID: 8599995
[TBL] [Abstract][Full Text] [Related]
18. Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter.
Sawado T; Igarashi K; Groudine M
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10226-31. PubMed ID: 11517325
[TBL] [Abstract][Full Text] [Related]
19. Erythroid AP-1/NF-E2 elements vary in their response to NF-E2.
Walters M; Andrews NC; Magis W; Martin DI
Exp Hematol; 1996 Feb; 24(3):445-52. PubMed ID: 8599974
[TBL] [Abstract][Full Text] [Related]
20. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
